Product
RC108
Aliases
RC108 for injection
3 clinical trials
3 indications
Indication
Solid TumorIndication
NSCLCIndication
Cancer of the Digestive SystemClinical trial
A Phase I Study to Evaluate the Safety, Pharmacokinetics, and Effect of RC108-ADC For Injection in Subjects With c-Met Positive Advanced Malignant Solid TumorsStatus: Recruiting, Estimated PCD: 2025-05-31
Clinical trial
An Open Single-arm Study to Evaluate the Safety, Tolerability, Efficacy of RC108 in Combination With Furmonertinib and Toripalimab in Patients With Advanced EGFR-mutated NSCLC Ib/II StudyStatus: Recruiting, Estimated PCD: 2025-09-01
Clinical trial
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of RC108 for Injection in the Treatment of Patients With c-Met-positiveAdvanced Digestive System Malignant TumorStatus: Recruiting, Estimated PCD: 2024-10-15